HealthTab to expand in North East London, Avricore Health (AVCRF) files 6-K

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

6-K

Rhea-AI Filing Summary

Avricore Health Inc. filed a Form 6-K as a foreign private issuer for January 2026. The filing primarily furnishes a news release titled “HealthTab to Expand Across North East London,” indicating the company is highlighting expansion activity related to its HealthTab platform in that region.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 6-K: How Foreign Companies Report to the SEC →

02/17/2026 - 06:15 AM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of January, 2026.

Commission File Number: 000-51848

Avricore Health Inc.

(Exact name of registrant as specified in its charter)

1120-789 West Pender St, Vancouver, BC, V6C 1H2

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): NO

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): NO

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Exhibits

The following exhibits are included in this form 6-K:

Exhibit No.		Description		Date Released
1		News Release- HealthTab to Expand Across North East London		January 14, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	AVRICORE HEALTH INC.

	By	“Kiki Smith”
Date: February 17, 2026		Kiki Smith
		Chief Financial Officer

SEC1815(04-09)

Persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a
currently valid OMB control number

Source: View Original Filing on SEC EDGAR

FAQ

What does Avricore Health Inc. (AVCRF) report in this Form 6-K?

Avricore Health Inc. reports a Form 6-K for January 2026 furnishing one exhibit. The exhibit is a news release titled “HealthTab to Expand Across North East London,” highlighting an expansion-related update tied to its HealthTab initiative.

What exhibit is included in Avricore Health’s January 2026 Form 6-K?

The Form 6-K includes a single exhibit: a news release titled “HealthTab to Expand Across North East London.” This exhibit was dated January 14, 2026 and is the core substantive attachment to the submission.

When was the HealthTab expansion news release dated for Avricore Health (AVCRF)?

The HealthTab expansion news release attached to the Form 6-K is dated January 14, 2026. It is included as Exhibit 1 and is described as “News Release- HealthTab to Expand Across North East London.”

Who signed Avricore Health Inc.’s January 2026 Form 6-K?

The Form 6-K was signed on behalf of Avricore Health Inc. by Kiki Smith. She signed in the capacity of Chief Financial Officer, with the signature dated February 17, 2026 in the submission’s signature block.

What type of issuer is Avricore Health Inc. in this Form 6-K?

Avricore Health Inc. files as a foreign private issuer using Form 6-K under Rules 13a-16 or 15d-16. This structure allows the company to furnish home-country reports and related documents to U.S. investors.

Filing Exhibits & Attachments

2 documents